Testicular cancer accounts for ∼1% of all cancers in men worldwide, with over 90% testicular being germ cell tumors (GCTs). Since the introduction multimodal therapy, GCTs have been among most curable solid tumors. However, some patients may develop late relapse, which is defined as recurrence at least two years after initial complete remission. Late particularly common teratomatous and associa...